SCHEMBL3974743

SCHEMBL3974743

N#Cc1c(O)ccc(C(=O)OC(=O)c2cc(-c3cccc(OCc4ccccc4)c3)co2)c1C(=O)NN

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GUSB P08236 1/20 0.39
NR1H4 Q96RI1 1/20 0.38
SMPD1 P17405 2/20 0.38
NR4A2 P43354 2/20 0.37
MRGPRX4 Q96LA9 1/20 0.37
MAPK1 P28482 2/20 0.37
MCL1 Q07820 1/20 0.37
GAA P10253 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
MAOB P27338 2/20 0.36
GPR132 Q9UNW8 1/20 0.36
ERN1 O75460 1/20 0.36
HDAC4 P56524 1/20 0.36
NAAA Q02083 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978669 0.92 MCL1 (0.44) GUSBSMPD1MCL1KDM4EALDH1A1
SCHEMBL3975723 0.89 GAA (0.38) MAPK1GAAKDM4EALDH1A1HPGD
SCHEMBL3977732 0.86 GUSB (0.39) GUSBNR1H4SMPD1NR4A2MAPK1
SCHEMBL3973934 0.86 MCL1 (0.44) MCL1HTTERN1
SCHEMBL3977882 0.86 GUSB (0.39) GUSBNR1H4SMPD1MAPK1GAA
SCHEMBL3976065 0.80 GPR132 (0.37) GUSBSMPD1MAPK1GPR132
SCHEMBL3975741 0.79 NR1H4 (0.38) NR1H4MAPK1GAAKDM4EALDH1A1
SCHEMBL3979525 0.79 MCL1 (0.40) GUSBMCL1KDM4EALDH1A1HPGD
SCHEMBL3976483 0.77 MAPK8 (0.39) SMPD1MAPK1MCL1
SCHEMBL3978012 0.77 MRGPRX4 (0.53) NR1H4SMPD1NR4A2MRGPRX4FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 GUSB 3454/4885NR1H4 288/4885SMPD1 2315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.